Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL-MYERS SQUIBB

  • FDA Approval
  • Dec. 30, 2024, 12:38 UTC
  • 31

FDA approve NIVOLUMAB;HYALURONIDASE-NVHY

Comment Full text

SAREPTA THERAPS INC

  • FDA Approval
  • Dec. 30, 2024, 12:38 UTC
  • 32

FDA approve ETEPLIRSEN

Comment Full text

BRISTOL-MYERS SQUIBB

  • FDA Approval
  • Dec. 30, 2024, 12:07 UTC
  • 45

FDA approve NIVOLUMAB;HYALURONIDASE-NVHY

Comment Full text

AMGEN INC

  • FDA Approval
  • Dec. 27, 2024, 17:44 UTC
  • 48

FDA approve USTEKINUMAB-AUUB

Comment Full text

AMGEN INC

  • FDA Approval
  • Dec. 27, 2024, 17:44 UTC
  • 50

FDA approve USTEKINUMAB-AUUB

Comment Full text

BEIGENE

  • FDA Approval
  • Dec. 27, 2024, 16:04 UTC
  • 49

FDA approve TISLELIZUMAB-JSGR

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 37

FDA approve LAMOTRIGINE

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 40

FDA approve CHOLESTYRAMINE

Comment Full text

PHARMOBEDIENT

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 30

FDA approve AZITHROMYCIN

Comment Full text

YUNG SHIN PHARM

  • FDA Approval
  • Dec. 27, 2024, 09:46 UTC
  • 30

FDA approve AZITHROMYCIN

Comment Full text
  • Previous
  • 166
  • 167
  • 168
  • 169
  • 170
  • Next

Search

News categories

  • Technical Exchange News(9869)
  • Event(407)
  • SEC News(167081)
  • FDA Approval(9320)
  • Company Report(721)
  • Business News(110969)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin